Related Experiment Video
Updated: Feb 20, 2026
Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
Prognostic value of soluble major histocompatibility complex class I polypeptide-related sequence A in non-small-cell
Roberto Cascone1, Annalisa Carlucci1, Matteo Pierdiluca1
1Thoracic Surgery Unit, Università degli Studi della Campania "Luigi Vanvitelli", Naples, Italy.
Abstract:
Soluble major histocompatibility complex class I polypeptide-related sequence A (sMICA) is a useful marker in surveillance of lung cancer. High serum sMICA level in patients with non-small-cell lung cancer (NSCLC) seems to be a poor prognostic factor being correlated with poor differentiation and advanced stage. However, the low specificity limits its role as a single prognostic marker of NSCLC, but its evaluation, in addition to standard serum markers, could improve the staging of NSCLC. Despite promising, all current studies are insufficient to assess the real efficiency of sMICA as a prognostic marker of NSCLC, and hence, future studies are required to validate it.
